Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Catalan Institute of Health | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether participation in a diabetes expert patients programme course is effective in self-management of a chronic condition such as diabetes, if it reduces Haemoglobin A glycosylated levels, improves patient's quality of life, and prevents the use of some health services.
The intervention consists in taking part in a diabetes expert patients programme course led by a teaching patient who has experience on chronic disease since he also suffers diabetes. The course is intended for 10 to 15 patients and it is scheduled on 9-weekly sessions (about two hours each session). A nurse supervises the group and observes it without taking part neither on dialogs nor presentations; this nurse helps teaching patient only on logistic needs.
First session main contents are on group operation rules (informed consent expression, confidentiality rules, ...), on reasons and expected results of this kind of self-care support programmes and on general aims and purposes. After explanations, patients are invited to answer a set of validated questionnaires on social, demographic and clinical data (including treatments and comorbidities), diabetes knowledge, self-care and self-assessment and quality of life. In this session body weight, arterial pressure and waist perimeter are also measured and registered. The most recent value (until three months before inclusion) of Haemoglobin A glycosylated will be collected from the lab information system.
The following sessions (from second to ninth) will approach several disease aspects like: what diabetes is, its diagnostic and treatment, acute and chronic complications, food and eating habits, physical exercise and healthy lifestyles, treatment (drugs and insulin) and disease self-control and self-care.
When intervention finishes, a follow-up period starts. At eighth and at 14th month from inclusion, participants will be summoned to provide again answers to questionnaires on knowledge, self-care, and quality of life. At both times, levels of Haemoglobin A glycosylated are also measured.
Patients assigned at control branch are summoned at inclusion to obtain complete baseline data, and also at month 8th and at month 14th. On these three occasions, these subjects answer the same questionnaires (including clinical, morbidity data and lab information) administered to intervention group patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Diabetes expert patients programme | Experimental | Diabetes expert patients programme: Participate in a scheduled and standardized expert patients programme course |
|
| No intervention | Placebo Comparator | Don't participate in a scheduled and standardized expert patients programme course |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Diabetes expert patients programme | Behavioral | Nine-weekly informative and educational sessions by a teaching patient who has experience on diabetes |
|
| Measure | Description | Time Frame |
|---|---|---|
| Glycosylated hemoglobin A | Change in glycosylated hemoglobin A percentage level | At baseline, and at 8th and 14th months of follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Health related quality of life | Change in scores from Diabetes quality of life questionnaire | At baseline, and at 8th and 14th months of follow-up |
| Health services utilization | Number of general practitioner consultations, number of outpatient visits, number of emergency department visits, number of hospital admissions and length of stay. All of them diabetes related. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Pere Roura-Poch, MD, MPH | Contact | +34.93.693.00.40 | proura@chv.cat | |
| Dolores Álamo-Junquera, MD, MPH | Contact | +34.93.693.00.40 | mdalamo.cc.ics@gencat.cat |
| Name | Affiliation | Role |
|---|---|---|
| Carme Boix, RN | Catalan Institute of Health | Principal Investigator |
| Pere Roura-Poch, MD, MPH | Catalan Institute of Health | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Catalan Health Institute, Barcelona District health Authority | Not yet recruiting | Barcelona | Catalonia | 08007 | Spain |
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 12 months before inclusion and 12 months after intervention ends |
| Catalan Health Institute, Sud metropolitan District health Authority | Not yet recruiting | L'Hospitalet de Llobregat | Catalonia | 08908 | Spain |
|
| Catalan Health Institute, Catalonia midlands District health Authority | Recruiting | Sant Fruitós de Bages | Catalonia | 08272 | Spain |
|
| D004700 | Endocrine System Diseases |